Skip to main content
Top
Published in: Diagnostic Pathology 1/2019

Open Access 01-12-2019 | Fluorescence in Situ Hybridization | Case Report

Pure secretory carcinoma in situ: a case report and literature review

Authors: Ying Yang, Zhiyuan Wang, Guoqing Pan, Shumo Li, Yingying Wu, Liu Liu

Published in: Diagnostic Pathology | Issue 1/2019

Login to get access

Abstract

Background

Secretory breast carcinoma is an exceptionally rare type of breast carcinoma. Only 5 cases of pure secretory carcinoma in situ have been reported in English literature. Herein, we reported a rare case of pure secretory breast carcinoma in situ.

Case presentation

The patient is a 38-year-old female with bloody discharge from the left nipple. Microscopically, the terminal-duct lobular units were enlarged and filled with tumor cells. The tumor cells were arranged in cystic, microcystic, solid and papillary pattern and formed a honeycomb-like appearance. The presence of intracellular and extracellular eosinphilic PAS-positive material was the most remarkable feature. Immunohistochemically, myoepithelial markers highlighted the complete presence of myoepithelial cells around the tumour nests. Tumour cells were strongly positive for S-100 and CK5/6, negative for ER, PR and HER2. Fluorescence in situ hybridization analysis showed ETV6-NTRK3 fusion.

Conclusion

Secretory carcinoma in situ shares the same morphological, immunohistochemical and molecular features with invasive secretory carcinoma except that the papillary growth pattern is more common in the introductal components. Cautions should be taken to distinguish secretory carcinoma in situ from other introductal lesions. Our report is an important supplement to the morphology spectrum of secretory breast carcinoma.
Literature
1.
go back to reference Eusebi V, SI N, Sneige A. Sapino. Secretory carcinoma. In: Sunil R, Lakhani IOE, Schnitt SJ, Tan PH, van de Vijver MJ, editors. WHO Classification of Tumours of the Breast. Lyon: International Agency for Research on Cancer (IARC); 2012. p. 71–2. Eusebi V, SI N, Sneige A. Sapino. Secretory carcinoma. In: Sunil R, Lakhani IOE, Schnitt SJ, Tan PH, van de Vijver MJ, editors. WHO Classification of Tumours of the Breast. Lyon: International Agency for Research on Cancer (IARC); 2012. p. 71–2.
2.
3.
go back to reference Tavassoli FA, Norris HJ. Secretory carcinoma of the breast. Cancer. 1980;45:2404–13.CrossRef Tavassoli FA, Norris HJ. Secretory carcinoma of the breast. Cancer. 1980;45:2404–13.CrossRef
4.
go back to reference Ozguroglu M, Tascilar K, Ilvan S, Soybir G, Celik V. Secretory carcinoma of the breast. Case report and review of the literature. Oncology. 2005;68:263–8.CrossRef Ozguroglu M, Tascilar K, Ilvan S, Soybir G, Celik V. Secretory carcinoma of the breast. Case report and review of the literature. Oncology. 2005;68:263–8.CrossRef
5.
go back to reference Vasudev P, Onuma K. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. Archives of pathology & laboratory medicine. 2011;135:1606–10.CrossRef Vasudev P, Onuma K. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. Archives of pathology & laboratory medicine. 2011;135:1606–10.CrossRef
6.
go back to reference Wong MJ-LA, Hui Ng RC, Tiong Lim AS, Cheok PY, Lim TH, Tan PH, Wong NS. ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma. Breast J. 2012;18:604–6.CrossRef Wong MJ-LA, Hui Ng RC, Tiong Lim AS, Cheok PY, Lim TH, Tan PH, Wong NS. ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma. Breast J. 2012;18:604–6.CrossRef
7.
go back to reference Beatty SM, SGO PK, Abraham SC, Reynolds C. Multicentric secretory carcinoma of the breast in a 35 year old woman mammographic appearance and the use of Core biopsy in preoperative management. Breast J. 1998;4:200–3.CrossRef Beatty SM, SGO PK, Abraham SC, Reynolds C. Multicentric secretory carcinoma of the breast in a 35 year old woman mammographic appearance and the use of Core biopsy in preoperative management. Breast J. 1998;4:200–3.CrossRef
8.
go back to reference Celik A, Kutun S, Pak I, Seki A, Cetin A. Secretory breast carcinoma with extensive intraductal component: case report. Ultrastruct Pathol. 2004;28:361–3.CrossRef Celik A, Kutun S, Pak I, Seki A, Cetin A. Secretory breast carcinoma with extensive intraductal component: case report. Ultrastruct Pathol. 2004;28:361–3.CrossRef
9.
go back to reference Kameyama K, Mukai M, Iri H, et al. Secretory carcinoma of the breast in a 51-year-old male. Pathol Int. 1998;48:994–7.CrossRef Kameyama K, Mukai M, Iri H, et al. Secretory carcinoma of the breast in a 51-year-old male. Pathol Int. 1998;48:994–7.CrossRef
10.
go back to reference Sato T, Iwasaki A, Iwama T, Kawai S, Nakagawa T, Sugihara K. A rare case of extensive ductal carcinoma in situ of the breast with secretory features. Rare tumors. 2012;4:e52.CrossRef Sato T, Iwasaki A, Iwama T, Kawai S, Nakagawa T, Sugihara K. A rare case of extensive ductal carcinoma in situ of the breast with secretory features. Rare tumors. 2012;4:e52.CrossRef
11.
go back to reference Strauss BL, Bratthauer GL, Tavassoli FA. STAT 5a expression in the breast is maintained in secretory carcinoma, in contrast to other histologic types. Hum Pathol. 2006;37:586–92.CrossRef Strauss BL, Bratthauer GL, Tavassoli FA. STAT 5a expression in the breast is maintained in secretory carcinoma, in contrast to other histologic types. Hum Pathol. 2006;37:586–92.CrossRef
12.
go back to reference Shui R, Cheng Y, Bai Q, Yang W. Secretory breast carcinoma with a papillary-predominant pattern: an unusual morphological variant. Histopathology. 2017;71:488–93.CrossRef Shui R, Cheng Y, Bai Q, Yang W. Secretory breast carcinoma with a papillary-predominant pattern: an unusual morphological variant. Histopathology. 2017;71:488–93.CrossRef
13.
go back to reference Li D, Xiao X, Yang W, et al. Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature. Mod Pathol. 2012;25:567–75.CrossRef Li D, Xiao X, Yang W, et al. Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature. Mod Pathol. 2012;25:567–75.CrossRef
14.
go back to reference Tognon CKS, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, Poremba C, Sorensen PH. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2:367–76.CrossRef Tognon CKS, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, Poremba C, Sorensen PH. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2:367–76.CrossRef
15.
go back to reference Laé MFP, Sastre-Garau X, Chouchane O, Sigal-Zafrani B, Vincent-Salomon A. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum. Mod Pathol. 2009;22:291–8.CrossRef Laé MFP, Sastre-Garau X, Chouchane O, Sigal-Zafrani B, Vincent-Salomon A. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum. Mod Pathol. 2009;22:291–8.CrossRef
16.
go back to reference Jin MS, Lee H, Woo J, et al. Integrated multi-Omic analyses support distinguishing secretory carcinoma of the breast from basal-like triple-negative breast Cancer. Proteomics Clin Appl. 2018:1700125.CrossRef Jin MS, Lee H, Woo J, et al. Integrated multi-Omic analyses support distinguishing secretory carcinoma of the breast from basal-like triple-negative breast Cancer. Proteomics Clin Appl. 2018:1700125.CrossRef
17.
go back to reference Horowitz DPSC, Connolly E, Gidea-Addeo D, Deutsch I. Secretory carcinoma of the breast: results from the survival, epidemiology and end results database. Breast. 2012;21:350–3.CrossRef Horowitz DPSC, Connolly E, Gidea-Addeo D, Deutsch I. Secretory carcinoma of the breast: results from the survival, epidemiology and end results database. Breast. 2012;21:350–3.CrossRef
18.
go back to reference Costa NM, Rodrigues H, Pereira H, Pardal F, Matos E. Secretory breast carcinoma—case report and review of the medical literature. Breast. 2004;13:353–5.CrossRef Costa NM, Rodrigues H, Pereira H, Pardal F, Matos E. Secretory breast carcinoma—case report and review of the medical literature. Breast. 2004;13:353–5.CrossRef
19.
go back to reference Del Castillo MCF, Arnould L, Croce S, Ribeiro A, Perot G, Hostein I, Geha S, Bozon C, Garnier A, Lae M, Vincent-Salomon A, MacGrogan G. Secretory breast carcinoma: a histopathologic and genomic Spectrum characterized by a joint specific ETV6-NTRK3 gene fusion. Am J Surg Pathol. 2015;39:1458–67.CrossRef Del Castillo MCF, Arnould L, Croce S, Ribeiro A, Perot G, Hostein I, Geha S, Bozon C, Garnier A, Lae M, Vincent-Salomon A, MacGrogan G. Secretory breast carcinoma: a histopathologic and genomic Spectrum characterized by a joint specific ETV6-NTRK3 gene fusion. Am J Surg Pathol. 2015;39:1458–67.CrossRef
20.
go back to reference Soyer T, Bajin İY, Orhan D, et al. Secretory breast carcinoma in a 6-year-old girl: mastectomy with sentinel lymph node dissection. Pediatr Surg Int. 2015;31:677–81.CrossRef Soyer T, Bajin İY, Orhan D, et al. Secretory breast carcinoma in a 6-year-old girl: mastectomy with sentinel lymph node dissection. Pediatr Surg Int. 2015;31:677–81.CrossRef
21.
go back to reference Shukla N, Roberts SS, Baki MO, et al. Successful targeted therapy of refractory pediatric ETV6-NTRK3 fusion-positive secretory breast carcinoma. JCO precision oncology. 2017;2017. Shukla N, Roberts SS, Baki MO, et al. Successful targeted therapy of refractory pediatric ETV6-NTRK3 fusion-positive secretory breast carcinoma. JCO precision oncology. 2017;2017.
Metadata
Title
Pure secretory carcinoma in situ: a case report and literature review
Authors
Ying Yang
Zhiyuan Wang
Guoqing Pan
Shumo Li
Yingying Wu
Liu Liu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2019
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-019-0872-7

Other articles of this Issue 1/2019

Diagnostic Pathology 1/2019 Go to the issue